Adaptimmune Therapeutics Plc (ADAPY)
0.0485
0.00 (0.00%)
USD |
OTCM |
Dec 11, 16:00
Adaptimmune Therapeutics Free Cash Flow: -193.83M for June 30, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Biodexa Pharmaceuticals Plc | -14.30M |
| NuCana Plc | -18.19M |
| Autolus Therapeutics Plc | -306.93M |
| Mereo BioPharma Group Plc | -33.02M |
| Bicycle Therapeutics Plc | -242.07M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -35.40M |
| Cash from Investing (Quarterly) | 18.84M |
| Cash from Financing (Quarterly) | 1.548M |
| Free Cash Flow Per Share (Quarterly) | -0.1343 |
| Free Cash Flow to Equity (Quarterly) | -35.45M |
| Free Cash Flow to Firm (Quarterly) | -34.57M |
| Free Cash Flow Yield | -1.55K% |